Marcus Ernst Peter

Marcus Ernst Peter

Auto-generated profile, based on publicly available information

Marcus Ernst Peter

Department of Medicine/Division Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, USA

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2008 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
Guido KroemerGuido Kroemer
Guido Kroemer
LGL Galluzzi
L Galluzzi
PVPeter Vandenabeele
Peter Vandenabeele
JAJ Abrams
J Abrams
EAE S Alnemri
E S Alnemri
GMG Melino
G Melino
Different types of cell death are often defined by morphological criteria, without a clear reference to precise biochemical mechanisms. The Nomenclature Committee on Cell Death (NCCD) proposes unified criteria for the definition of cell death and of its different morphologies, while formulating several caveats against the misuse of words and concepts that slow down progress in the area of cell death research. Authors, reviewers and editors of scientific periodicals are invited to abandon expressions like ‘percentage apoptosis’ and to replace them with more accurate descriptions of the biochemical and cellular parameters that are actually measured. Moreover, at the present stage, it should be accepted that caspase-independent mechanisms can cooperate with (or substitute for) caspases in the execution of lethal signaling pathways and that ‘autophagic cell death’ is a type of cell death occurring together with (but not necessarily by) autophagic vacuolization. This study details the 2009 recommendations of the NCCD on the use of cell death-related terminology including ‘entosis’, ‘mitotic catastrophe’, ‘necrosis’, ‘necroptosis’ and ‘pyroptosis’.

1 June 1996 in Cell
Verified
Journal Article
Closed access
MMMarta Muzio
Marta Muzio
ACArul M Chinnaiyan
Arul M Chinnaiyan
FKFrank C Kischkel
Frank C Kischkel
KOKaren O'Rourke
Karen O'Rourke
ASAndrej Shevchenko
Andrej Shevchenko
VDVishva M Dixit
Vishva M Dixit

16 March 1998 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
CSCarsten Scaffidi
Carsten Scaffidi
SFSimone Fulda
Simone Fulda
ASAnu Srinivasan
Anu Srinivasan
CFClaudia Friesen
Claudia Friesen
FLFeng Li
Feng Li
MPMarcus E. Peter
Marcus E. Peter

15 July 2011 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
LGL Galluzzi
L Galluzzi
IVIlio Vitale
Ilio Vitale
JAJ M Abrams
J M Abrams
EAE S Alnemri
E S Alnemri
EBE H Baehrecke
E H Baehrecke
Guido KroemerGuido Kroemer
Guido Kroemer

30 October 2011 in Nature Medicine
Verified
Journal Article
Open access
PDF file
KNKristin Nieman
Kristin Nieman
HKHilary A Kenny
Hilary A Kenny
CPCarla V Penicka
Carla V Penicka
ALAndras Ladanyi
Andras Ladanyi
RBRebecca Buell-Gutbrod
Rebecca Buell-Gutbrod
ELErnst Lengyel
Ernst Lengyel
Ovarian tumors preferentially metastasize to the omentum, a peritoneal fat layer. This report proposes that the reasons for this predilection stem from the growth advantage conferred by adipocytes on ovarian cancer cells. Adipocytes seem to promote homing of cancer cells through adipokine secretion, and direct contact of the two cell types promotes metabolic changes that result in lipid transfer from adipocytes to tumor cells. Environmental-driven metabolic adaptations could be exploited to target omental metastasis. Intra-abdominal tumors, such as ovarian cancer1,2, have a clear predilection for metastasis to the omentum, an organ primarily composed of adipocytes. Currently, it is unclear why tumor cells preferentially home to and proliferate in the omentum, yet omental metastases typically represent the largest tumor in the abdominal cavities of women with ovarian cancer. We show here that primary human omental adipocytes promote homing, migration and invasion of ovarian cancer cells, and that adipokines including interleukin-8 (IL-8) mediate these activities. Adipocyte–ovarian cancer cell coculture led to the direct transfer of lipids from adipocytes to ovarian cancer cells and promoted in vitro and in vivo tumor growth. Furthermore, coculture induced lipolysis in adipocytes and β-oxidation in cancer cells, suggesting adipocytes act as an energy source for the cancer cells. A protein array identified upregulation of fatty acid–binding protein 4 (FABP4, also known as aP2) in omental metastases as compared to primary ovarian tumors, and FABP4 expression was detected in ovarian cancer cells at the adipocyte-tumor cell interface. FABP4 deficiency substantially impaired metastatic tumor growth in mice, indicating that FABP4 has a key role in ovarian cancer metastasis. These data indicate adipocytes provide fatty acids for rapid tumor growth, identifying lipid metabolism and transport as new targets for the treatment of cancers where adipocytes are a major component of the microenvironment.

1 April 2008 in Genes & Development
Verified
Journal Article
Open access
PDF file
SPSun-Mi Park
Sun-Mi Park
AGArti B. Gaur
Arti B. Gaur
ELErnst Lengyel
Ernst Lengyel
MPMarcus E. Peter
Marcus E. Peter
Cancer progression has similarities with the process of epithelial-to-mesenchymal transition (EMT) found during embryonic development, during which cells down-regulate E-cadherin and up-regulate Vimentin expression. By evaluating the expression of 207 microRNAs (miRNAs) in the 60 cell lines of the drug screening panel maintained by the Nation Cancer Institute, we identified the miR-200 miRNA family as an extraordinary marker for cells that express E-cadherin but lack expression of Vimentin. These findings were extended to primary ovarian cancer specimens. miR-200 was found to directly target the mRNA of the E-cadherin transcriptional repressors ZEB1 (TCF8/δEF1) and ZEB2 (SMAD-interacting protein 1 [SIP1]/ZFXH1B). Ectopic expression of miR-200 caused up-regulation of E-cadherin in cancer cell lines and reduced their motility. Conversely, inhibition of miR-200 reduced E-cadherin expression, increased expression of Vimentin, and induced EMT. Our data identify miR-200 as a powerful marker and determining factor of the epithelial phenotype of cancer cells.